BehindLines

Antimicrobial resistance: many plans, limited action

· BehindLines newsroom

A growing number of countries now have a plan against antimicrobial resistance, but major gaps remain in testing and care, the World Health Organization (WHO) says in new figures released on Monday 16 November, ahead of the global awareness week on the subject (18 to 24 November).

More plans, few resources

According to WHO, 173 countries say they have drawn up a national plan, against 79 in 2017. CIDRAP, which covers the same release, gives a different figure: 179 countries, or 89% of member countries, against 79 in 2017. The two sources therefore give different totals, which this article reports without choosing between them. On resources, WHO says only 22% of countries state that they have both the funding required and a complete rollout of their plan; CIDRAP speaks of 42 countries (22%) that have turned their plan into funded programmes. According to WHO, these figures come from an annual self-assessment survey (TrACSS) completed in 2026 by 183 countries: it rests on what countries themselves declare.

Diagnostic gaps

WHO stresses that testing remains inadequate in most countries: 36% say they own a national reference lab fitted out to check the chosen bacteria and fungi, far from the target of 80% of countries by 2030. Per WHO, 63% of countries have guidance on proper use of antimicrobials, while a little over half have systems to monitor their antibiotic consumption and resistance; CIDRAP gives 67% for the guidelines, 58% for monitoring use and 56% for monitoring resistance. Silvia Bertagnolio of WHO said at a press briefing, as quoted by CIDRAP, that without tests one cannot see where resistance is emerging.

A problem measured in 2023

WHO recalls that roughly one in six laboratory-confirmed bacterial infections worldwide in 2023 resisted antibiotics. CIDRAP quotes Jean Pierre Nyemazi, acting head of the WHO department on the subject, who judges that the world is at a pivotal moment; according to CIDRAP, resistant infections caused more than one million deaths in 2021 and contributed to nearly five million. To help laboratories, WHO also released two documents: a catalogue of diagnostic tests and a set of procedures.

Why it matters

When medicines lose their power against resistant bacteria, common infections become harder to treat and procedures such as surgery, childbirth or cancer care become riskier, WHO recalls. It also notes that a plan on paper does not automatically mean that patients are safe. The 2026 theme of the awareness week, "One Health, one action: prevent resistance now", stresses how the health of humans, animals, crops and nature is intertwined.

Sources